Skip to content

NeoGenomics NEO Reportable Segment — Interest Expense

Similar metrics at other companies

Crescent Energy logo
CRGYReportable Segment — Interest Expense
$104.57M+42.9%
Synaptics logo
SYNAReportable Segment — Interest Expense
$2.55M-50.0%
Indivior Pharmaceuticals, Inc.
 logo
INDVReportable Segment — Interest Expense
$7M-41.7%
ADT logo
ADTReportable Segment — Interest Expense
$100.72M-18.2%
F&G Annuities & Life logo
FGReportable Segment — Interest Expense
$41M+2.5%
Global Business Travel Group logo
GBTGReportable Segment — Interest Expense
-$27M-12.5%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's reportable segment — interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's reportable segment — interest expense?
NeoGenomics (NEO) reported reportable segment — interest expense of $598K in Q1 2026.
How has NeoGenomics's reportable segment — interest expense changed year-over-year?
NeoGenomics's reportable segment — interest expense decreased by 63.0% year-over-year, from $1.62M to $598K.
What is the long-term trend for NeoGenomics's reportable segment — interest expense?
Over 3 years (2022 to 2025), NeoGenomics's reportable segment — interest expense has grown at a -20.9% compound annual growth rate (CAGR), from $7.58M to $3.75M.
What does reportable segment — interest expense mean?
This represents the total cost of debt financing incurred by the reportable business segment during the period. It reflects the interest obligations associated with loans, credit facilities, or other debt instruments allocated to the segment's operations.